how much money is being poored in anti againg
Quick Scoop: A recent Wall Street Journal-based analysis says billionaires have poured more than $5 billion into longevity and anti-aging ventures over the past 25 years, with average funding rounds for lifespan-extending tech reaching nearly $43 million this year.
What that money is funding
Most of the big cash is going into biotech , especially cell reprogramming, epigenetic reset research, and other attempts to slow or reverse aging at the cellular level.
The field has also moved from theory toward early human testing, such as Life Biosciences’ first patient dosing in a Phase 1 trial.
Big-name backers
The coverage highlights major investors like Peter Thiel, Sam Altman, Jeff Bezos, Yuri Milner, Eric Schmidt, and Vinod Khosla as some of the people driving the surge in funding.
Examples cited include Thiel’s more than $700 million across longevity companies and Altman’s $180 million investment in Retro Bioscience.
How to read the number
That $5 billion figure is best understood as a running total from wealthy individual investments, not the entire anti-aging market or all spending on skincare, wellness, and supplements.
So the real amount “being poured in” depends on whether you mean venture funding, billionaire money, pharma R&D, or consumer anti-aging products.
In plain terms
Anti-aging is no longer a niche hobby for the ultra-rich; it has become a serious, expensive biotech race.
At the same time, the results are still early, and the science has not yet produced a proven way to stop aging in humans.
| Metric | Reported amount | Source |
|---|---|---|
| Billionaire longevity investment total | More than $5 billion over 25 years | |
| Sam Altman’s Retro Bioscience investment | $180 million | |
| Peter Thiel’s longevity investments | Over $700 million | |
| Average funding round this year | Nearly $43 million |